Literature DB >> 31707668

Optimized Production of Lentiviral Vectors for CAR-T Cell.

Pablo Diego Moço1, Mário Soares de Abreu Neto1, Daianne Maciely Carvalho Fantacini1, Virgínia Picanço-Castro2.   

Abstract

Advances in the use of lentiviral vectors for gene therapy applications have created a need for large-scale manufacture of clinical-grade viral vectors for transfer of genetic materials. Lentiviral vectors can transduce a wide range of cell types and integrate into the host genome of dividing and nondividing cells, resulting in long-term expression of the transgene both in vitro and in vivo. In this chapter, we present a method to transfect human cells, creating an easy platform to produce lentiviral vectors for CAR-T cell application.

Entities:  

Keywords:  Chimeric antigen receptor; Human cell line; Lentiviral vectors; Titration; Transfection

Mesh:

Substances:

Year:  2020        PMID: 31707668     DOI: 10.1007/978-1-0716-0146-4_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Adoptive T-cell Immunotherapy: Perfecting Self-Defenses.

Authors:  Raphaëlle Toledano Zur; Galit Adler; Katerina Shamalov; Yair Tal; Chen Ankri; Cyrille J Cohen
Journal:  Exp Suppl       Date:  2022

2.  Infection Temperature Affects the Phenotype and Function of Chimeric Antigen Receptor T Cells Produced via Lentiviral Technology.

Authors:  Xin Jin; Wenyi Lu; Meng Zhang; Xia Xiong; Rui Sun; Yunxiong Wei; Xiaoyuan He; Mingfeng Zhao
Journal:  Front Immunol       Date:  2021-04-19       Impact factor: 7.561

Review 3.  Impact of Manufacturing Procedures on CAR T Cell Functionality.

Authors:  Norihiro Watanabe; Feiyan Mo; Mary Kathryn McKenna
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

4.  Aberrant splicing events caused by insertion of genes of interest into expression vectors.

Authors:  Yun Cheng; Xiao-Zhuo Kang; Pearl Chan; Zi-Wei Ye; Chi-Ping Chan; Dong-Yan Jin
Journal:  Int J Biol Sci       Date:  2022-07-18       Impact factor: 10.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.